CDH1 and renal carcinoma: Additionally, an impact of IL-15 on a progression of renal cancer is suspected, as particular isoforms of this cytokine act as a down-regulator of E-cadherin, resulting in increased risk of cell neoplastic transformation and tumor growth [17,34].